Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
In the inaugural CEO Insights video, Nick Jue, CEO of ING DiBa, shares insights in an exclusive interview.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Steven van Rijswijk, CEO of ING
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
BlackRock's Perspective on Bitcoin ETFs and the Evolution of Financial Instruments | Larry Fink, CEO, BlackRock Inc.
00:10:00
helping find smart capital for every stage of company|Greg Castle,Managing Partner,Anorak Ventures
00:10:00
The CEO of Rimini Street Inc. discusses the creation of a support system for enterprise software support products and services.
00:10:00
The Untold Story of dLocal: A Conversation with CEO Sebastian Kanovich | Sebastián Kanovich - CEO of dLocal
00:10:00
Navigating the Future of Liquid Alts: Insights from Bob Elliott of Unlimited Funds | Bob Elliott - CIO, Unlimited Funds
00:10:00
TTG's New Technology Stack and Information Security | Jim Evans, Co-Founder , TTG Financial Inc.
00:10:00
President of the Management Board of XTPL, Filip Granek in an interview for Biznes24 TV 23 03 2022 | Filip Granek, CEO, XTPL SAXTP:WSE
00:10:00
Besra Gold CEO Ray Shaw Discusses Promising Drill Results and Strong Investment Potential at Jugan Project | Ray Shaw, CEO , Besra Gold Inc.
00:10:00
Optimal 401(k) Investment Strategies with Adam Taylor | Adam Taylor, CEO, Taylor Financial.
00:10:00
Blockchain Revolution: Kevin Soltani on the Future of Gaming and NFTs | Kevin Soltani, CEO, Semper Fortis Esports PLC.
00:00:00
Evgen Pharma "delighted" with cash position after promising first half - Dr Huw Jones , CEO, Evgen Pharma
00:10:00
Northwest Fund: Stable Returns with 9% Note Rate and Predictable Performance